Genetic and epigenetic mechanisms of NASH
- 18 December 2015
- journal article
- review article
- Published by Springer Science and Business Media LLC in Hepatology International
- Vol. 10 (3), 394-406
- https://doi.org/10.1007/s12072-015-9689-y
Abstract
Along with the obesity epidemic, the prevalence of nonalcoholic fatty liver disease (NAFLD) has increased exponentially. The histological disease spectrum of NAFLD ranges from bland fatty liver (hepatic steatosis), to the concomitant presence of inflammation and ballooning which defines nonalcoholic steatohepatitis (NASH). The latter can progress in a subset to fibrosis, leading ultimately to cirrhosis and hepatocellular carcinoma. The past decade has seen tremendous advances in our understanding of the genetic and epigenetic bases of NAFLD, mainly through the application of high end technology platforms including genome-wide association studies (GWAS). These have helped to define common gene variants (minor allele frequency > 5 %) that contribute to the NAFLD phenotype. Looking to the future, these discoveries are expected to lead to improved diagnostics, the personalization of medicine, and a better understanding of the pathophysiological underpinnings that drive the transition from NAFLD to steatohepatitis and fibrosis, leading to the identification of novel therapeutic targets. In this review, we summarize data on the current state of knowledge with regard to the genetic and epigenetic mechanisms for the development of NASH.Keywords
This publication has 98 references indexed in Scilit:
- Hdac3 Is Essential for the Maintenance of Chromatin Structure and Genome StabilityCancer Cell, 2010
- Hepatic-Specific Disruption of SIRT6 in Mice Results in Fatty Liver Formation Due to Enhanced Glycolysis and Triglyceride SynthesisCell Metabolism, 2010
- A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescentsJournal of Hepatology, 2010
- Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: Impact of liver methylation of the peroxisome proliferator-activated receptor γ coactivator 1α promoterJournal of Hepatology, 2010
- Patatin-like phospholipase domain-containing 3/adiponutrin deficiency in mice is not associated with fatty liver diseaseJournal of Hepatology, 2010
- The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver diseaseJournal of Hepatology, 2010
- Nuclear receptor corepressor and histone deacetylase 3 govern circadian metabolic physiologyNature, 2008
- Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expressionJournal of Hepatology, 2008
- Global variation in copy number in the human genomeNature, 2006
- Silencing of microRNAs in vivo with ‘antagomirs’Nature, 2005